[ATP activity of myocardial actomyosin complex in patients with dilated cardiomyopathy]

Likars'Ka Sprava
|August 25, 2001
PubMed

Insights

Dilated cardiomyopathy (DCMP) shows reduced actomyosin ATP activity. However, calcium sensitivity remains unchanged, while the patient

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Biochemistry

Background:

  • Dilated cardiomyopathy (DCMP) is a severe heart condition characterized by impaired cardiac function.
  • Actomyosin ATP activity and tropomyosin-troponin complex function are critical for myocardial contractility.

Purpose of the Study:

  • To investigate the ATP activity of actomyosin in DCMP.
  • To assess the impact of tropomyosin-troponin regulatory complexes from DCMP patients on actomyosin activity.
  • To evaluate calcium ion sensitivity of actomyosin in DCMP.

Main Methods:

  • Biochemical assays measuring ATP activity of actomyosin.
  • Isolation and functional assessment of tropomyosin-troponin complexes from human myocardial samples.
  • Analysis of calcium ion (Ca2+) sensitivity.

Main Results:

  • A significant 1.5-fold decline in actomyosin ATP activity was observed in DCMP.
  • No significant difference in Ca2+ sensitivity was found between normal and DCMP actomyosins.
  • Tropomyosin-troponin complexes from DCMP patients exhibited enhanced regulatory activity compared to normal controls.

Conclusions:

  • Reduced actomyosin ATP activity is a key feature of DCMP.
  • Alterations in tropomyosin-troponin complex function may contribute to DCMP pathophysiology.
  • Further research into these molecular mechanisms could reveal therapeutic targets for DCMP.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...